Three Essential Concerns for a Safe and Effective Aseptic Filling Process Three Essential Concerns for a Safe and Effective Aseptic Filling Process By Ray Peck|2020-01-11T09:30:10-05:00July 30th, 2019|Generic & Commercial Drug Manufacturing Services, Latest Publications|
Patenting Physical Forms in the Pharmaceutical Industry Patenting Physical Forms in the Pharmaceutical Industry By Ray Peck|2020-01-12T16:50:09-05:00May 28th, 2019|Formulation Development & Clinical Trial Materials, Latest Publications|
Optimizing Upstream and Downstream Processes in Biologics Manufacturing Yields Significant Savings Optimizing Upstream and Downstream Processes in Biologics Manufacturing Yields Significant Savings By Ray Peck|2020-01-11T09:39:19-05:00May 28th, 2019|Generic & Commercial Drug Manufacturing Services, Latest Publications|
Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain By Ray Peck|2020-01-11T09:41:28-05:00May 28th, 2019|Generic & Commercial Drug Manufacturing Services, Latest Publications|
Despite Individual Fluctuations, the Collective Success Rate of Monoclonal Antibody Therapies Continues to Rise Despite Individual Fluctuations, the Collective Success Rate of Monoclonal Antibody Therapies Continues to Rise By Ray Peck|2020-01-11T09:42:29-05:00May 28th, 2019|Formulation Development & Clinical Trial Materials|
Quality Control in Commercial Tablet Manufacturing Quality Control in Commercial Tablet Manufacturing By Ray Peck|2020-01-11T09:43:09-05:00May 15th, 2019|Generic & Commercial Drug Manufacturing Services|
Emerging Alternatives to Animal Models for Toxicology Testing Emerging Alternatives to Animal Models for Toxicology Testing By Ray Peck|2020-01-11T09:44:22-05:00May 9th, 2019|Preclinical|
Best Practices Extend Beyond GLP for Investigational New Drug (IND) Enabling Studies Best Practices Extend Beyond GLP for Investigational New Drug (IND) Enabling Studies By Ray Peck|2020-01-11T09:45:52-05:00May 8th, 2019|Generic & Commercial Drug Manufacturing Services, Uncategorized|
Clinical Trial Material Manufacturing in an Age of Increasing Regulatory Oversight Clinical Trial Material Manufacturing in an Age of Increasing Regulatory Oversight By Ray Peck|2020-01-11T09:46:29-05:00April 16th, 2019|Formulation Development & Clinical Trial Materials, Generic & Commercial Drug Manufacturing Services|
Coating Processes in Commercial Tablet Manufacturing Coating Processes in Commercial Tablet Manufacturing By Ray Peck|2020-01-11T09:47:47-05:00April 7th, 2019|Generic & Commercial Drug Manufacturing Services|
